Glucosylceramide synthetase inhibitor
Blocks glucosylation of ceramide by inhibiting UDP-glucose:ceramide glucosyltransferase (glucosylceramide synthetase). Inhibits the expression of cell surface glycolipid antigens and inhibits the growth of cultured rabbit skin fibroblasts. Possesses antitumor activity and inhibits Lewis lung carcinoma cell metastasis in vitro. Useful tool for studying the effects of cellular glycosphingolipid depletion. Enhances the apoptotic response to ionizing radiation by enhancing the ceramide signal.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
| Alternative Name |
D,L-threo-PDMP . hydrochloride, DL-PDMP |
|---|---|
| Appearance |
White to off-white solid. |
| CAS |
80938-69-8 |
| Couple Target |
Glucosylceramide synthetase |
| Couple Type |
Inhibitor |
| Formula |
C23H38N2O3 . HCl |
| MW |
390.6 . 36.5 |
| Purity |
≥98% (TLC) |
| Solubility |
25mg/ml soluble in 100% ethanol, DMSO or water (50°C, vortex or sonicate). |
| Technical Info / Product Notes |
Note: Product is not sterile. |
Handling & Storage
| Use/Stability |
As indicated on product label or CoA when stored as recommended. Stable for up to 1 year after receipt when stored at -20°C. Solutions are stable for up to 3 months when stored at -20°C. |
|---|---|
| Long Term Storage |
-20°C |
| Shipping |
Blue Ice |
| Regulatory Status |
RUO – Research Use Only |
|---|
- Glycolysis regulates KRAS plasma membrane localization and function through defined glycosphingolipids: J. Liu, et al.; Nat. Commun. 14, 465 (2023), Abstract
- Probing Physical Properties of the Cellular Membrane in Senescent Cells by Fluorescence Imaging: J.H. Wi, et al.; J. Phys. Chem. B 125, 10182 (2021), Abstract
- C16:0 ceramide effect on melanoma malignant behavior and glycolysis depends on its intracellular or exogenous location: Liu, R., Cao, K., et al.; Am. J. Transl. Res. 12, 1123 (2020), Abstract
- PDMP induces rapid changes in vacuole morphology in Arabidopsis root cells: Krüger, F., Krebs, M., et al.; J. Exp. Bot. 64, 529 (2013), Abstract
- Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing: C. Rodriguez-Lafrasse, et al.; Int. J. Cancer 101, 589 (2002), Abstract
- Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases: C.S. Rani, et al.; J. Biol. Chem. 270, 2859 (1995), Abstract — Full Text
- Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway: A.G. Rosenwald; Biochemistry 31, 3581 (1992), Abstract
- Use of PDMP for the Study of Glycosphingolipid Functions: N.S. Radin and J.-I. Inokuchi; Trends Glycosci. Glycotechnol. 3, 200 (1991), Full Text
- Rapid kidney changes resulting from glycosphingolipid depletion by treatment with a glucosyltransferase inhibitor: G.S. Shukla, et al.; Biochim. Biophys. Acta 1083, 101 (1991), Abstract
- Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action: J.-I. Inokuchi, et al.; Cancer Res. 50, 6731 (1990), Abstract
- Effect of an inhibitor of glucosylceramide synthesis on cultured rabbit skin fibroblasts: K.-I. Uemura, et al.; J. Biochem. 108, 525 (1990), Abstract
- Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells: J.-I. Inokuchi, et al.; J. Cell Physiol. 141, 573 (1989), Abstract
- Antitumor activity via inhibition of glycosphingolipid biosynthesis: J.-I. Inokuchi, et al.; Cancer Lett. 38, 23 (1987), Abstract
- Preparation of the active isomer of 1-phenyl-2-decanoylamino-3- morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase: J. Inokuchi & N.S. Radin; J. Lipid Res. 28, 565 (1987), Abstract
- Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain: R.R. Vunnam & N.S. Radin; Chem. Phys. Lipids 26, 265 (1980), Abstract
Related Products
| CAS | 38966-21-1 |
|---|---|
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | (+)-3,3’,4’,5,7-Flavanpentol . H2O |
|---|---|
| CAS | 225937-10-0 |
| Purity | ≥98% (HPLC) |
| Alternative Name | 6-(6-Methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,8-dihydrofuro[3,4-E][1,3]benzodioxol-8-ol, (+)-Decumbensine |
|---|---|
| CAS | 6883-44-9 |
| Purity | ≥98% (HPLC) |
| Alternative Name | (3S,3aR,4R,4aS,8aR,9aS)-4-[(1E)-2-[(2R,6S)-1,6-Dimethyl-2-piperdinyl]ethenyl]decahydro-3-methyl-naphtho[2,3-c]furan-1(3H)-one |
|---|---|
| CAS | 6879-74-9 |
| Couple Type | Inhibitor |
| Purity | ≥98% |
Last modified: May 29, 2024
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form
Lab Essentials
AMPIVIEW® RNA probes
Enabling Your Projects
GMP Services
Bulk Solutions
Research Travel Grant
Have You Published Using an Enzo Product?
